Publication
The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII
| dc.contributor.author | Diniz, MJ | |
| dc.contributor.author | Dias, M | |
| dc.contributor.author | Falcão, MT | |
| dc.contributor.author | Cruz, M | |
| dc.date.accessioned | 2013-01-24T10:37:40Z | |
| dc.date.available | 2013-01-24T10:37:40Z | |
| dc.date.issued | 2000 | |
| dc.identifier.citation | IN: 16th International Congress on Thrombosis, 2000, 5 a 8 Mai. Porto, Portugal | por |
| dc.identifier.uri | http://hdl.handle.net/10400.17/953 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Serviço de Imuno-Hemoterapia do Hospital de S. José | por |
| dc.subject | Factor VIII | por |
| dc.subject | Factor VIIa | por |
| dc.title | The Use of Recombinant Activated FVII (rFVIIa, Novoseven) in the Treatment of a Lifethreatening Retroperitoneal Hemorrhage in a Hemophilia A Patient with Inhibitors to FVIII | por |
| dc.type | other | |
| dspace.entity.type | Publication | |
| rcaap.rights | openAccess | por |
| rcaap.type | other | por |